[HTML][HTML] Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment

M Zhang, W Hu, C Cai, Y Wu, J Li, S Dong - Materials Today Bio, 2022 - Elsevier
Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …

Nanomedical approaches in the realm of rheumatoid arthritis

AF Radu, SG Bungau - Ageing research reviews, 2023 - Elsevier
Rheumatoid arthritis (RA) is a heterogeneous autoimmune inflammatory disorder defined by
the damage to the bone and cartilage in the synovium, which causes joint impairment and …

Microenvironment-responsive nanocarriers for targeted bone disease therapy

M Li, B Yu, S Wang, F Zhou, J Cui, J Su - Nano Today, 2023 - Elsevier
Nanomedicines with controlled drug release have received increasing attention as an
advanced therapeutic strategy for bone diseases. To traverse biological barriers towards …

[HTML][HTML] “Smart” stimuli-responsive biomaterials revolutionizing the theranostic landscape of inflammatory arthritis

S Nag, S Mohanto, MG Ahmed… - Materials Today Chemistry, 2024 - Elsevier
Inflammatory arthritis is a growing worldwide concern, afflicting millions of individuals and
leading to a depreciating quality of life, significant morbidity, and subsequent healthcare …

Bioresponsive immunotherapeutic materials

J Han, T Sheng, Y Zhang, H Cheng, J Gao… - Advanced …, 2024 - Wiley Online Library
The human immune system is an interaction network of biological processes, and its
dysfunction is closely associated with a wide array of diseases, such as cancer, infectious …

Active targeted nanoformulations via folate receptors: State of the art and future perspectives

C Martín-Sabroso, AI Torres-Suárez… - Pharmaceutics, 2021 - mdpi.com
In normal tissues, the expression of folate receptors is low and limited to cells that are
important for embryonic development or for folate reabsorption. However, in several …

Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis

S Pandey, N Rai, A Mahtab, D Mittal, FJ Ahmad… - International Journal of …, 2021 - Elsevier
Rheumatoid arthritis (RA), an autoimmune inflammatory disorder is currently incurable.
Methotrexate and Teriflunomide are routinely prescribed drugs but their uses are limited due …

Nanomaterials manipulate macrophages for rheumatoid arthritis treatment

S Li, J Su, W Cai, J Liu - Frontiers in Pharmacology, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic, progressive, and systemic inflammatory autoimmune
disease, characterized by synovial inflammation, synovial lining hyperplasia and …

Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan‐Based Nanocarriers

AE Caprifico, E Polycarpou, PJS Foot… - Macromolecular …, 2021 - Wiley Online Library
Chitosan‐based nanocarriers (ChNCs) are considered suitable drug carriers due to their
ability to encapsulate a variety of drugs and cross biological barriers to deliver the cargo to …

Glycol chitosan stabilized nanomedicine of lapatinib and doxorubicin for the management of metastatic breast tumor

N Kaur, P Sharma, Mimansa, M Jaganathan… - Drug Delivery and …, 2023 - Springer
Advanced breast cancer is known to be highly evasive to conventional therapeutic regimes
with a 5-year survival rate of less than 30% compared to over 90% for early stages. Although …